Drug industry

Article Abstract:

Drug companies profited from two major events in 1994. The Food and Drug Administration began to hasten the approval process for new drugs, allowing companies to bring them to market faster and with fewer tests. In addition, the GATT treaty signed in Uruguay gives companies additional patent protection on drugs, allowing greater profit on new drugs. If the newly elected Congress can be convinced to streamline regulations even further, stock prices will certainly see an upward trend in 1995.

Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Drugs, Investment advice, Securities Investment Advice, Industry Overview, Eli Lilly and Co., Pfizer Inc., Investment advisers, SmithKline Beecham PLC, Warner-Lambert Co., Genzyme Corp., Immunex Corp., IVAX Corp., Mylan Laboratories Inc., Perrigo Co., Schering-Plough Corp., Sicor Inc., CYGN, GENZ, ICN, IMNX, IVX, LLY, PFE, SGP, WLA, Rhone-Poulenc S.A., Valeant Pharmaceuticals International, Merck & Company Inc., MKC, XOMA, Glaxo Holdings PLC, Wellcome PLC, Hoechst Marion Roussel Inc., Upjohn Co., Cygnus Therapeutic Systems, Roberts Pharmaceutical Corp., XOMA Corp., MYL, PRR, RPCX

---

Chemical/diversified industry

Article Abstract:

Stocks in the chemical industry will outperform the market for the next six to twelve months. European markets are improving and the chemical industry in the US will grow 2% to 3% for the next several years. Fertilizer demand has grown and most other chemicals are seeing large volume gains in the global economy. Several stocks offer long-term return potential and some of the larger producers provide good current income.

Industrial Chemicals, Basic Chemical Manufacturing, Agricultural Chemicals, Fertilizer Manufacturing, Fertilizers, 3M Co., MMM, Fertilizer industry, Chemical industry, Imperial Chemical Industries PLC, Air Products and Chemicals Inc., Cabot Corp., ChemFirst Corp., Dexter Corp., Eastman Chemical Co., IMC Global Inc., Millipore Corp., Norsk Hydro ASA, Novo Nordisk A/S, PPG Industries Inc., Pall Corp., APD, CBT, DEX, EMN, GR, GRA, MIL, PPG, PLL, TRA, Potash Corporation Of Saskatchewan Inc., Goodrich Corp., W.R. Grace & Co., Akzo N.V., FRM, Freeport-McMoRan Resource Partners L.P., FRP

---

Drug industry

Article Abstract:

Drug industry stocks are outperforming the general stock market and drug industry earnings are increasing. Industry profits are expected to increase at an above average rate until 2000. The average gain in drug stocks for the top 11 multinational firms was 15.6% for 3d qtr 1996. Earnings growth is expected to be 125 to 15% for 1996 and 1997.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Pharmaceutical industry, Cygnus Inc., AMGN

Similar abstracts:

• Abstracts: Chemical/diversified industry. part 2
• Abstracts: Petroleum (producing) industry. Natural gas (diversified) industry
• Abstracts: Petroleum (producing) industry. Natural gas (diversified) industry. part 2
• Abstracts: European diversified industry
• Abstracts: Gold silver mining industry. Gold silver. Gold/silver

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.